Netherlands (NL)

Comparison between clinical gait and daily-life gait assessments of fall risk in older people (2017) Brodie MA, Coppens MJ, Ejupi A, Gschwind YJ, Annegarn J, Schöne D, Wieching R, et al. Journal article The GlyT1 Inhibitor Bitopertin Ameliorates Allodynia and Hyperalgesia in Animal Models of Neuropathic and Inflammatory Pain (2017) Armbruster A, Neumann E, Koetter V, Hermanns H, Werdehausen R, Eulenburg V Journal article Scale-dependent diffusion anisotropy in nanoporous silicon. (2017) Kondrashova D, Lauerer A, Mehlhorn D, Jobic H, Feldhoff A, Thommes M, Chakraborty D, et al. Journal article, Original article Salt Sensitivity of Angiogenesis Inhibition-Induced Blood Pressure Rise: Role of Interstitial Sodium Accumulation? (2017) Lankhorst S, Severs D, Marko L, Rakova N, Titze J, Mueller DN, Danser AHJ, Van Den Meiracker AH Journal article STRUCTURAL DAMAGE PROGRESSION IN PATIENTS TREATED WITH METHOTREXATE, BARICITINIB MONOTHERAPY OR BARICITINIB plus METHOTREXATE BASED ON THEIR LEVEL OF CLINICAL RESPONSE IN THE PHASE 3 RA-BEGIN STUDY (2017) Van Der Heijde D, Durez P, Schett G, Naredo E, Ostergaard M, Meszaros G, Bello N, et al. Conference contribution Secukinumab provides sustained improvements in the signs and symptoms of active psoriatic arthritis: 2-year efficacy and safety results from the phase 3 randomised, double-blind, placebo-controlled trial FUTURE 1 (2017) Rech J, Reinhardt M, Kavanaugh A, Geusens P, Mpofu S Conference contribution Long Noncoding RNA H19X Is a Key Regulator of Apoptosis and Proliferation of Fibroblasts in Systemic Sclerosis and Other TGF beta-riven Fibrotic Diseases (2017) Pachera E, Wunderlin A, Assassi S, Salazar G, Bertoncelj MF, Dobrota R, Brock M, et al. Conference contribution OPTIMAL DOSE OF TOCILIZUMAB FOR THE TREATMENT OF GIANT CELL ARTERITIS: EFFICACY, SAFETY, AND EXPOSURE-EFFICACY ANALYSIS FROM GIACTA (2017) Stone JH, Tuckwell K, Dimonaco S, Klearman M, Mallalieu NL, Aringer M, Blockmans D, et al. Conference contribution PREDICTION OF PROGRESSIVE SKIN THICKENING IN EARLY DIFFUSE SYSTEMIC SCLEROSIS USING THREE-MONTHLY SKIN SCORES FROM THE EUROPEAN SCLERODERMA OBSERVATIONAL STUDY (ESOS) (2017) Herrick A, Peytrignet S, Pan X, Hesselstrand R, Mouthon L, Brown E, Czirjak L, et al. Conference contribution LONG NONCODING RNA H19X AS A NEW THERAPEUTIC TARGET FOR FIBROSIS (2017) Pachera E, Wunderlin A, Assassi S, Salazar G, Frank-Bertoncelj M, Dobrota R, Brock M, et al. Conference contribution